ADAR1 Capital Management LLC insider trades
Open-market stock purchases and sales by ADAR1 Capital Management LLC, 10% Owner at Tenax Therapeutics, Inc, from SEC Form 4 filings since Aug 9, 2024.
Track record: 63% of 35 scored buys are up 5% or more since purchase, averaging +4%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 21, 2026 | TENX Tenax Therapeutics, Inc | Bought | $551K |
| Oct 20, 2026 | TENX Tenax Therapeutics, Inc | Bought | $406K |
| Oct 19, 2026 | INM InMed Pharmaceuticals Inc | Bought | $1.4K |
| Oct 19, 2026 | TENX Tenax Therapeutics, Inc | Bought | $507K |
| Oct 16, 2026 | INM InMed Pharmaceuticals Inc | Bought | $1 |
| Oct 15, 2026 | INM InMed Pharmaceuticals Inc | Bought | $1.3K |
| Oct 14, 2026 | INM InMed Pharmaceuticals Inc | Bought | $10.7K |
| Oct 13, 2026 | INM InMed Pharmaceuticals Inc | Bought | $750 |
| Oct 8, 2026 | INM InMed Pharmaceuticals Inc | Bought | $3K |
| Oct 7, 2026 | INM InMed Pharmaceuticals Inc | Bought | $4.1K |
| Oct 6, 2026 | INM InMed Pharmaceuticals Inc | Bought | $7.4K |
| Oct 5, 2026 | INM InMed Pharmaceuticals Inc | Bought | $24.2K |
| Oct 2, 2026 | INM InMed Pharmaceuticals Inc | Bought | $11K |
| Oct 1, 2026 | INM InMed Pharmaceuticals Inc | Bought | $21.8K |
| Sep 16, 2026 | INM InMed Pharmaceuticals Inc | Bought | $10.8K |
| Sep 15, 2026 | INM InMed Pharmaceuticals Inc | Bought | $70.4K |
| Sep 14, 2026 | INM InMed Pharmaceuticals Inc | Bought | $36.9K |
| Sep 3, 2026 | TENX Tenax Therapeutics, Inc | Bought | $1.6M |
| Sep 2, 2026 | TENX Tenax Therapeutics, Inc | Bought | $338K |
| Sep 1, 2026 | TENX Tenax Therapeutics, Inc | Bought | $322K |
| Aug 31, 2026 | TENX Tenax Therapeutics, Inc | Bought | $723K |
| Aug 24, 2026 | TENX Tenax Therapeutics, Inc | Bought | $188K |
| Aug 21, 2026 | TENX Tenax Therapeutics, Inc | Bought | $1.3M |
| Aug 20, 2026 | TENX Tenax Therapeutics, Inc | Bought | $360K |
| Jul 31, 2026 | NXTC NextCure, Inc | Bought | $16.4K |
Companies traded
- TENX Tenax Therapeutics, Inc: 10 buys, last Oct 21, 2026
- INM InMed Pharmaceuticals Inc: 17 buys, last Oct 19, 2026
- NXTC NextCure, Inc: 12 buys, last Jul 31, 2026
- RLYB Rallybio Corp: 14 buys, last May 19, 2026
- KROS Keros Therapeutics, Inc: 5 buys, 3 sales, last Oct 15, 2025
- PIRS Pieris Pharmaceuticals, Inc: 3 buys, last Aug 12, 2024
Get free alerts when ADAR1 Capital Management LLC files a new trade →